Home » Authors » Anette Breindl

Articles by Anette Breindl

Specific Starvation Gene Joins Sirtuins As Longevity Target

May 3, 2007

By Anette Breindl

Novel Resistance Mechanism To Iressa, Tarceva Discovered

April 30, 2007

By Anette Breindl

Novel Resistance Mechanism To Iressa, Tarceva Discovered

April 30, 2007

By Anette Breindl

New Knockout Type Elucidates MiRNA's Immune System Roles

April 27, 2007

By Anette Breindl

New Knockout Type Elucidates MiRNA's Immune System Roles

April 27, 2007

By Anette Breindl

Running Stop Signs For A Broad-Spectrum Antigenetic

April 24, 2007

By Anette Breindl

Running Stop Signs For A Broad-Spectrum Antigenetic

April 24, 2007

By Anette Breindl

Immunotherapy Success May Depend On Inhibiting Inhibitors

April 19, 2007

By Anette Breindl

Immunotherapy Success May Depend On Inhibiting Inhibitors

April 19, 2007

By Anette Breindl

Cetuximab Results Illustrate Trials, Tribulations Of Clinic

April 18, 2007

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 24, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.